4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-033749
Chief Executive Officer sold 1,220 shares at $3.11 ($3,794)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-10-18 | Sale | −1,220 | $3.11 | $3,794 | 252,300 | D |
| Open-market sales · 1,220 sh · avg $3.11 · $3,794 | |||||||
Loading xslF345X03/doc4.xml…